n-3 polyunsaturated fatty acids in phospholipid or triacylglycerol form attenuate nonalcoholic fatty liver disease via mediating cannabinoid receptor 1/adiponectin/ceramide pathway
Yanfang Chen, Zekai Fan, Xiang Gao, Fang Zhou, Xiaofei Guo, Andrew J. Sinclair, Duo Li
Topics & Concepts
EndocrinologyAdiponectinInternal medicineNonalcoholic fatty liver diseasePolyunsaturated fatty acidEicosapentaenoic acidSteatosisFatty liverDocosahexaenoic acidCeramideInsulin resistanceChemistryBiologyFatty acidInsulinBiochemistryMedicineApoptosisDiseaseLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseAlcohol Consumption and Health Effects